ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Cancer Research Advocate Survey

Thank you for your interest in the ASCO Targeted Agent and Profiling Utilization Registry (TAPUR) clinical study, which offers patients with advanced cancer access in a research setting to molecularly-targeted cancer drugs that are already commercially available for treating at least one kind of cancer. The TAPUR clinical study will collect data on outcomes to help learn the best uses of these drugs outside of indications approved by the Food and Drug Administration (FDA).

Cancer patients and research advocates are important partners in this process of planning and conducting clinical studies, as well as in increasing public and patient awareness of research opportunities.

ASCO wants to hear from patients and research advocates who would like to keep informed about TAPUR as well as those who are interested in being directly involved. Please circulate this survey to fellow patient and cancer research advocates.

Question Title

* 1. If you are interested in receiving communication and updates regarding TAPUR, please provide the following information:

Name (First & Last) *

Suffix

Name of Organization I am affiliated with (if applicable)

Address

City/Town

State/Province

ZIP/Postal Code

Preferred Email Address *

Phone Number

Question Title

* 2. There are a limited number of opportunities to become directly involved in the TAPUR clinical study. Some of these opportunities will be restricted to very experienced research advocates. TAPUR will also provide opportunities for additional advocates to learn about how they may contribute to this effort.

Are you interested in volunteering your time?

Yes